Winfried März

147.3k total citations · 3 hit papers
662 papers, 24.3k citations indexed

About

Winfried März is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Winfried März has authored 662 papers receiving a total of 24.3k indexed citations (citations by other indexed papers that have themselves been cited), including 243 papers in Surgery, 221 papers in Endocrinology, Diabetes and Metabolism and 170 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Winfried März's work include Lipoproteins and Cardiovascular Health (196 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (125 papers) and Vitamin D Research Studies (74 papers). Winfried März is often cited by papers focused on Lipoproteins and Cardiovascular Health (196 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (125 papers) and Vitamin D Research Studies (74 papers). Winfried März collaborates with scholars based in Germany, Austria and Netherlands. Winfried März's co-authors include Stefan Pilz, Bernhard O. Boehm, Eberhard Ritz, Hubert Scharnagl, Marcus E. Kleber, Vera Krane, Christoph Wanner, Bernhard R. Winkelmann, Tanja B. Grammer and Heinrich Wieland and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Winfried März

637 papers receiving 23.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

2005 1.8k citations Christoph Wanner, Vera Krane et al. profile →
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10

2001 676 citations Winfried März et al. profile →
Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease

2012 499 citations Stefan Pilz, Winfried März et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Winfried März	7.2k	5.6k	4.8k	4.4k	4.0k	662	24.3k
Moses Elisaf	7.6k 1.1×	7.0k 1.2×	3.7k 0.8×	1.4k 0.3×	3.5k 0.9×	692	21.3k
Ian H. de Boer	3.0k 0.4×	6.3k 1.1×	3.7k 0.8×	3.7k 0.8×	2.4k 0.6×	325	19.8k
Stephan J. L. Bakker	3.2k 0.4×	4.5k 0.8×	4.2k 0.9×	1.4k 0.3×	4.2k 1.1×	889	24.2k
Jesús Egido	5.1k 0.7×	3.0k 0.5×	5.6k 1.2×	2.3k 0.5×	10.6k 2.7×	621	31.6k
Casper G. Schalkwijk	2.3k 0.3×	5.9k 1.0×	4.4k 0.9×	1.8k 0.4×	4.1k 1.0×	483	21.5k
Hiromi Rakugi	2.8k 0.4×	3.6k 0.6×	6.7k 1.4×	1.2k 0.3×	4.8k 1.2×	604	21.5k
Yaping Zhang	3.9k 0.5×	3.5k 0.6×	6.9k 1.4×	1.6k 0.4×	2.9k 0.7×	200	28.3k
Ömer Toprak	2.7k 0.4×	4.6k 0.8×	4.5k 0.9×	1.1k 0.2×	2.3k 0.6×	31	19.4k
Alberto Ortíz	3.8k 0.5×	2.4k 0.4×	3.0k 0.6×	2.6k 0.6×	8.7k 2.2×	847	28.9k
Claudio Borghi	3.2k 0.4×	2.8k 0.5×	7.0k 1.5×	1.6k 0.4×	2.1k 0.5×	623	17.2k

Countries citing papers authored by Winfried März

Since Specialization

Citations

This map shows the geographic impact of Winfried März's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winfried März with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winfried März more than expected).

Fields of papers citing papers by Winfried März

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winfried März. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winfried März. The network helps show where Winfried März may publish in the future.

Co-authorship network of co-authors of Winfried März

This figure shows the co-authorship network connecting the top 25 collaborators of Winfried März. A scholar is included among the top collaborators of Winfried März based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winfried März. Winfried März is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blanke, Philipp, et al.. (2025). Cardiovascular risk assessment enhanced by automated machine learning in a multi-phase study. Scientific Reports. 15(1). 36474–36474.

Delgado, Graciela E., Hubert Scharnagl, R. Siekmeier, et al.. (2025). Comparing Inflammatory Biomarkers in Cardiovascular Disease: Insights from the LURIC Study. International Journal of Molecular Sciences. 26(15). 7335–7335. 1 indexed citations

Dawczynski, Christine, Peter Schlattmann, Michael Kiehntopf, et al.. (2025). Reduction of cardiovascular risk factors by the diet – Evaluation of the MoKaRi concept by a parallel-designed randomized study. Lipids in Health and Disease. 24(1). 88–88. 1 indexed citations

Hasselbalch, Hans Carl, Vibe Skov, Lasse Kjær, et al.. (2024). The CHIP-clinic as the catalyst of preventive medicine. SHILAP Revista de lepidopterología. 3. 1 indexed citations

Scharnagl, Hubert, Graciela E. Delgado, Bernhard K. Krämer, et al.. (2024). Clinical and genetic diagnosis of familial hypercholesterolaemia in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study. European Heart Journal - Quality of Care and Clinical Outcomes. 10(7). 632–640. 1 indexed citations

Marttila, Saara, Pashupati P. Mishra, Leo-Pekka Lyytikäinen, et al.. (2024). Identification and functional characterisation of DNA methylation differences between East- and West-originating Finns. Epigenetics. 19(1). 2397297–2397297. 1 indexed citations

Cremer, Sebastian, Tina Rasper, Stephen Zewinger, et al.. (2024). Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease. Circulation. 150(10). 746–757. 18 indexed citations

Zelzer, Sieglinde, Andreas Meinitzer, Dietmar Enko, et al.. (2024). Classification of Vitamin D Status Based on Vitamin D Metabolism: A Randomized Controlled Trial in Hypertensive Patients. Nutrients. 16(6). 839–839. 3 indexed citations

Screever, Elles M., A. Rogier van der Velde, Herman H.W. Silljé, et al.. (2023). Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance. International Journal of Molecular Sciences. 24(5). 4415–4415. 2 indexed citations

10.

Theiler‐Schwetz, Verena, Christian Trummer, Martin Grübler, et al.. (2023). Associations of Parameters of the Tryptophan–Kynurenine Pathway with Cardiovascular Risk Factors in Hypertensive Patients. Nutrients. 15(2). 256–256. 5 indexed citations

11.

Marx, Nikolaus, Christoph Wanner, Joachim Jankowski, et al.. (2023). Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study. Clinical Kidney Journal. 16(10). 1612–1621.

12.

Silbernagel, Günther, Yan Chen, Marcus E. Kleber, et al.. (2023). Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation. European Heart Journal. 44(25). 2335–2345. 11 indexed citations

13.

Leitner, Deborah R., Harald Sourij, Tatjana Stojaković, et al.. (2022). Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study. Biomedicines. 10(1). 193–193. 4 indexed citations

14.

Wallentin, Lars, Niclas Eriksson, Tanja B. Grammer, et al.. (2021). Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study. PLoS Medicine. 18(1). e1003513–e1003513. 86 indexed citations

15.

Delgado, Graciela E., Bernhard K. Krämer, Christine Dawczynski, et al.. (2021). Alcohol consumption and mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Atherosclerosis. 335. 119–125. 8 indexed citations

16.

Schneppenheim, Reinhard, Maria A. Brehm, Tobias Obser, et al.. (2018). The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction. Blood. 133(4). 356–365. 19 indexed citations

17.

Koller, Lorenz, Marcus E. Kleber, Georg Goliasch, et al.. (2014). C-Reactive Protein Predicts Mortality in Patients Referred for Coronary Angiography and Symptoms of Heart Failure With Preserved Ejection Fraction. European Journal of Heart Failure. 16(7). 758–766. 54 indexed citations

18.

Thomas, G. Neil, Bríain ó Hartaigh, Jos A. Bosch, et al.. (2012). Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome. Diabetes Care. 35(5). 1158–1164. 92 indexed citations

19.

Wehr, Elisabeth, Stefan Pilz, Bernhard O. Boehm, et al.. (2011). Low Free Testosterone is Associated with Heart Failure Mortality in Older Men Referred for Coronary Angiography. European Journal of Heart Failure. 13(5). 482–488. 69 indexed citations

20.

Drechsler, Christiane, Andreas Meinitzer, Stefan Pilz, et al.. (2011). Homoarginine, Heart Failure, and Sudden Cardiac Death in Haemodialysis Patients. European Journal of Heart Failure. 13(8). 852–859. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact